✨ Your Portfolio is fetched and updated from zerodha.
Nano Hospitals
Market Cap
₹206 Cr.
P/E
63.07

Key Ratios

Market cap
Market cap
206 Cr
PE
PE
63.07
Prom Holding
Prom Holding
61.28 %
ROE (%)
ROE (%)
2.45
ROCE (%)
ROCE (%)
5.57
Div Yield (%)
Div Yield (%)
-
Sales
Sales
22.65 Cr
OPM (%)
OPM (%)
18.88 %
Debt to Equity
Debt to Equity
0.21

About

Aashka Hospitals Limited is a healthcare service provider dedicated to offering quality servic… Read more
Low
70
52W Range
High
124
  • Aashka Hospitals
  • Fortis MalarHospital
  • Tejnaksh Healthcare
  • TJI Hospitals

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statement

New
Edit rows

Forensics

7 Yes

Positive for this company

1 Neutral

Neutral for this company

7 No

Negative for this company

2 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Operational Metrics

    Select a Metric
    • Hospital Occupancy Rate (%)
    • Average Length Of Stay (Days)
    • Operational Beds (.)
    • Inpatient Procedures (Thousand)

    Peer Comparison

    FAQs on Aashka Hospitals Ltd. Business

    Aashka Hospitals Limited is an integrated healthcare service provider, offering quality services including prevention, treatment, and rehabilitation. It has treated over 2000 COVID-19 patients and aims to become a leading healthcare provider with modern facilities.

    Aashka Hospitals major competitors are Fortis MalarHospital, Tejnaksh Healthcare, Global Longlife Hosp, Family Care Hospital, KMC Speciality Hosp, Dr Agarwals Eye Hsp, Shalby.
    Market Cap of Aashka Hospitals is ₹206 Crs.
    While the median market cap of its peers are ₹123 Crs.

    Aashka Hospitals seems to be financially stable compared to its competitors.
    The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

    Company Filing

    2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
    Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
    Earnings Release Sep
    Investor Presentation
    Conference Call
    Conference Call SummaryCon Call Summary

    Discussions & Analysis

    Ideas Dashboard
    Results
    Timeline
    Watchlist
    Portfolio
    Alerts
    Stock Screener
    Market
    Raw Material